15205-11-5

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-4-fluorobenzylamine is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Chemical Industry:
In the chemical industry, 2-Chloro-4-fluorobenzylamine serves as an intermediate in the production of specialty chemicals. Its versatility allows for the creation of a wide range of chemical products with specific properties and applications.
Used in Drug Discovery and Development:
2-Chloro-4-fluorobenzylamine is utilized as a key component in drug discovery and development processes. Its incorporation into molecular structures can lead to the identification of novel compounds with potential medicinal properties, enhancing the repertoire of available treatments for various diseases and conditions.

InChI:InChI=1S/C7H7ClFN/c8-7-3-6(9)2-1-5(7)4-10/h1-3H,4,10H2

Upstream product

• 45767-66-6 2-chloro-4-fluorobenzylbromide 

Downstream Products

• 1026476-32-3 {2-[3-(2-chloro-4-fluoro-benzyl)-5-(2-fluoro-phenyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 1065330-04-2 N-[(2-chloro-4-fluorophenyl)methyl]-6-oxo-1-(phenylmethyl)-2-piperidinecarboxamide 
• 635698-58-7 tert-butyl 2-chloro-4-(2-chloro-4-fluorobenzylamino)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-6-carboxylate 
• 1071814-17-9 N-[(2-chloro-4-fluorophenyl)methyl]-2-(1,4-dimethyl-1H-pyrazol-5-yl)acetamide 
• 1082827-33-5 N-[(2-chloro-4-fluorophenyl)methyl]-2-(5-methyl-1-phenyl-1H-pyrazol-4-yl)acetamide trifluoroacetate 
• 1082825-67-9 N-[(2-chloro-4-fluorophenyl)methyl]-2-[3,5-dimethyl-1-(2-phenylethyl)-1H-pyrazol-4-yl]acetamide 
• 1082826-45-6 2-(3-butyl-5-methyl-1-phenyl-1H-pyrazol-4-yl)-N-[(2-chloro-4-fluorophenyl)methyl]acetamide 
• 1082826-55-8 ethyl [4-(2-{[(2-chloro-4-fluorophenyl)methyl]amino}-2-oxoethyl)-3,5-dimethyl-1H-pyrazol-1-yl]acetate 
• 1082827-05-1 N-[(2-chloro-4-fluorophenyl)methyl]-2-[1-(2-hydroxy-2-methylpropyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetamide 
• 1082828-00-9 N-[(2-chloro-4-fluorophenyl)methyl]-2-[1-(triphenylmethyl)-1H-pyrazol-4-yl]acetamide 
• 1082827-13-1 N-[(2-chloro-4-fluorophenyl)methyl]-2-[1-(2-hydroxyethyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]acetamide 
• 1082824-99-4 N-[(2-chloro-4-fluorophenyl)methyl]-2-[1-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetamide 
• 1082825-11-3 N-[(2-chloro-4-fluorophenyl)methyl]-2-[1-(4-chlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetamide 
• 1082826-97-8 4-[4-(2-([(2-chloro-4-fluorophenyl)methyl]amino)-2-oxoethyl)-3,5-dimethyl-1H-pyrazol-1-yl]benzamide 

Relevant academic research and scientific papers

PYRIDAZINONES AND METHODS OF USE THEREOF

Disclosed are compounds according to Formula (A), and related tautomers and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (A).

THIENOPYRIMIDINES

Thienopyrimidines of the formula (I) and their physiologically acceptable salts, in which R1, R2 and X are as defined in claim 1, exhibit phosphodiesterase V inhibition and can be employed for the treatment of illnesses of the cardiovascular system and for the treatment and/or therapy of impotence.